PDUFA REAUTHORIZATION LINKED TO MANAGEMENT CHANGES BY REP. BARTON; USER FEE BILL HINGES ON APPROPRIATIONS PROCESS, SAYS HEALTH SUBCMTE. CHAIRMAN BILIRAKIS
This article was originally published in The Gray Sheet
Executive Summary
House Commerce/Oversight Subcommittee Chairman Joe Barton (R-Tex.) is continuing to push for management changes at FDA as a higher priority than prescription drug user fee reauthorization.